Most common bacterial agents in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease

  • Violeta Kolarov Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia
  • Biljana Zvezdin Institute of Oncology of Vojvodina, Sremska Kamenica, Serbia
  • Mrina Djurić Institute of Oncology of Vojvodina, Sremska Kamenica, Serbia
  • Mirjana Hadnadjev Institute of Oncology of Vojvodina, Sremska Kamenica, Serbia
  • Sanja Hromiš Institute of Oncology of Vojvodina, Sremska Kamenica, Serbia
  • Katarina Nikoletić Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
  • Bojana Trivić Boehringer Ingelheim Serbia, Belgrade, Serbia
Keywords: pulmonary disease, chronic obstructive, acute disease, diagnostic techniques and procedures, sputum, bacteriological techniques, pseudomonas aeruginosa, haemophilus influenzae, streptococcus pneumoniae, mortality,

Abstract


Background/Aim. Infection is the major cause of acute exacerbation of chronic obstructive pulmonary disease (AE-COPD). The aim of the study was to establish the most common bacterial agents of AE-COPD in patients hospitalized in a tertiary medical care institution. Methods. This retrospective study included the patients hospitalized due to infective AE-COPD in the Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica in a 12-month period. We evaluated clinical data, spirometry, pathogen etiology in the patients with positive sputum findings and disease outcome. Results. The study included a total of 81 patients, 47 (58.02%) males and 34 (41.97%) females of the mean age of 65.7 years. The mean history of the disease was 14.5 years. The median forced expiratory volume in one second (FEV1) was 30.12%. The most common isolated pathogens was Pseudomonas aeruginosa (n = 36; 38.29%), followed by Haemophilus influenzae (n = 25; 26.59%) and Streptococcus pneumoniae (n = 16; 17.02%). Coinfections were present in 9 (9.57%) of the patients. The median FEV1 values of 28.67%, 37.23%, and 42.26% were registered in the patients with Pseudomonas aeruginosa, Haemophilus influenza, and Streptococcus pneumonia induced infection, respectively. The case fatality rate (CFR) was 6.2%. Of the deceased, 100% had Pseudomonas aeruginosa-induced infection. A statistically significant difference in FEV1 values was registered between the patients with and without Pseudomonas aeruginosa in their sputum finding (p = 0.016). Conclusion. The most common pathogens in patients with AE-COPD were Pseudomonas aeruginosa, Haemophilus influenzae, and Streptococcus pneumonia. The CFR was 6.2%. All (100%) deceased patients had the infection induced by Pseudomonas aeruginosa.

Author Biographies

Violeta Kolarov, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia

Izabrana u zvanje asistenta decembra 2012. godine

Odbranila doktorsku disertaciju 2014.

Biljana Zvezdin, Institute of Oncology of Vojvodina, Sremska Kamenica, Serbia

Odeljenje za astmu

Prof. dr sc. med.

Mrina Djurić, Institute of Oncology of Vojvodina, Sremska Kamenica, Serbia

Odeljenje za opštu pulmologiju

Prof. dr sc. med.

Mirjana Hadnadjev, Institute of Oncology of Vojvodina, Sremska Kamenica, Serbia

Centar za mikrobiologiju

Doktor mikrobiolog

Sanja Hromiš, Institute of Oncology of Vojvodina, Sremska Kamenica, Serbia

Odeljenje za astmu

Primarijus dr

Katarina Nikoletić, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

Zavod za nuklearnu medicinu

Prim. dr sci. med.

Bojana Trivić, Boehringer Ingelheim Serbia, Belgrade, Serbia
Mr ph spec.

References

World Health Organisation. Chronic obstructive pulmonary disease (COPD). Available from: http://www.who.int/respiratory/copd/en

Boixeda R, Rabella N, Sauca G, Delgado M, Martinez-Costa X, Mauri M, et al. Microbiological study of patients hospitalized for acute exacerbation of chronic obstructive pulmonary dis-ease (AE-COPD) and the usefulness of analytical and clinical parameters in its identification (VIRAE study). Int J Chron Obstruct Pulmon Dis 2012; 7: 327−35.

Beasley V, Joshi PV, Singanayagam A, Molyneaux PL, Johnston SL, Mallia P. Lung microbiology and exacerbation in COPD. Int J Chron Obstruct Pulmon Dis 2012; 7: 555−69.

Global Strategy for the Diagnosis, Management and Prevention of chronic obstructive pulmonary disease. Available from: http://www.goldcopd.org/

Lin S, Kuo P, Hsueh P, Yang P, Kuo S. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa. Respirology 2007; 12(1): 81−7.

Larsen MV, Janner JH, Nielsen SD, Friis-Møller A, Ringbaek T, Lange P. Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital. Scand J Infect Dis 2009; 41(1): 26−32. 41(1): 26-32.

Matkovic Z, Miravitlles M. Chronic bronchial infection in COPD. Is there an infective phenotype. Respir Med 2013; 107(1): 10−22.

Sethi S, Sethi R, Eschberger K, Lobbins P, Cai X, Grant BJ, et al. Airway Bacterial Concentrations and Exacerbations of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care 2007; 176(4): 356−61.

Lode H, Allewelt M, Balk S, De Roux A, Mauch H, Niederman M, et al. A prediction model for bacterial etiology in acute exacerbations of COPD. Infection 2007; 35(3): 143−9.

Sapey E, Stockley RA. COPD exacerbations. 2: aetiology. Thorax 2006; 61(3): 250−8.

Health Protection Agency. Standard Unit. Evaluations and Standards Laboratory. Investigation of bronchoalveolar lavage, sputum and associated specimens: BSOP57i1. London, UK: Health Protection Agency, Technical Services; 2005.

Isenberg HD. Specimen Collection, Transport, and Acceptability. In: Isenberg HD, editor. Clinical Microbiology Procedures Handbook. Washington, DC: American Society for Microbiology; 2004. p. 1.5.1−1.5.18.

York MK. Aerobic Bacteriology. In: Isenberg HD, editor. Clinical Microbiology Procedures Handbook. Washington DC: American Society for Microbiology; 2004. p. 3.1.1.-3.18.2.1.

Ko FW, Ip M, Chan PK, Fok JP, Chan MC, Ngai JC, et al. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD. Chest 2007; 131(1): 44−52.

Ko FW, Ng TK, Li TS, Fok JP, Chan MC, Wu AK, et al. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong. Respir Med 2005; 99(4): 454−60.

Groenewegen KH, Wouters EF. Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study. Respir Med 2003;7(7): 770−7.

Published
2017/06/21
Section
Original Paper